| Literature DB >> 35016644 |
Jörg Reifart1,2, Stefan Göhring3, Alexander Albrecht4, Winfried Haerer5, Benny Levenson4, Gerd Ringwald6, Patrick Gärtner7, Nicolaus Reifart7.
Abstract
BACKGROUND: In 2015 and 2018, European Society of Cardiology guidelines for percutaneous coronary intervention (PCI) favoring radial access over femoral access were published. These recommendations were based on randomized trials suggesting that patients treated radially experienced reduced bleeding complications and all-cause mortality. We aimed to assess acceptance and results of radial access in a real-world scenario by analyzing all PCI cases in the Quality Assurance in Invasive Cardiology (QuIK) registry.Entities:
Keywords: Access site complications; Acute myocardial infarction; BNK; Coronary artery disease; Percutaneous coronary intervention; Radial access
Mesh:
Year: 2022 PMID: 35016644 PMCID: PMC8753849 DOI: 10.1186/s12872-021-02283-0
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Case characteristics
| Radial, n = 46,687 | Femoral, n = 143,230 | ||
|---|---|---|---|
| Age | 67.70 ± 10.56 | 67.68 ± 10.97 | 0.14 ns |
| Cardiogenic shock | 0.4% (n = 202) | 1.7% (n = 2379) | < 0.0009*** |
| Prior CABG | 2.3% (n = 1074) | 2.1% (n = 3024) | 0.015* |
| SCAD | 78.1% | 67.9% | < 0.0009*** |
| STEMI | 2.8% | 8.0% | < 0.0009*** |
| NSTEMI | 6.6% | 11.9% | < 0.0009*** |
Z test/Mann–Whitney–Wilcoxon Test
Extremely significant ****; Extremely significant ***; Very significant **; Significant *; Not significant ns
Fig. 1Increase of radial access over time
PCI success rates
| Radial (%) | Femoral (%) | ||
|---|---|---|---|
| All PCI | 92.6 | 91.6 | < 0.0009*** |
| SCAD | 92.3 | 91.7 | < 0.0009*** |
| NSTEMI | 95.3 | 92.3 | < 0.0009*** |
| STEMI | 92.2 | 91.2 | 0.073 |
| Unstable angina | 94.3 | 91.2 | < 0.0009*** |
| Cardiogenic shock | 84.1 | 86.5 | 0.4 |
Pearson’s Chi-squared test with Yates’ continuity correction
Procedural results and complications
| All PCI | Radial 24.6% | Femoral 75.4% | |
|---|---|---|---|
| Procedure time (min) | 35.51 ± 24.06 | 37.99 ± 25.42 | < 0.0009*** |
| Fluoroscopy time | 8.26 ± 7.96 | 8.30 ± 8.99 | 0.45 |
| Contrast dye (ml) | 68.32 ± 41.30 | 77.01 ± 51.66 | < 0.0009*** |
| Dose area product (Gycm2) | 27.75 ± 33.24 | 33.42 ± 40.6 | < 0.0009*** |
| Major bleeding | 0.07 (n = 31) | 0.2% (n = 280) | < 0.0009*** |
| MACE overall | 0.12% (n = 54) | 0.24% (n = 342) | < 0.0009*** |
| Myocardial infarction | 0.04% (n = 18) | 0.03% (n = 49) | 0.77 |
| TIA/stroke | 0.03 (n = 13) | 0.03% (n = 49) | 0.95 |
| Death | 0.05% (n = 23) | 0.18% (n = 256) | < 0.0009*** |
| Access site complication overall | 0.2% (n = 108) | 0.8% (n = 1036) | < 0.0009*** |
| All SCAD | 36,446 (27.3%) | 97,273 (72.7%) | |
| Procedure time (min) | 70.2 ± 42.4 | 79.9 ± 54.4 | < 0.0009*** |
| Fluoroscopy time | 8.21 ± 7.99 | 8.35 ± 9.19 | < 0.009** |
| Contrast dye (ml) | 70.3 ± 42.3 | 80 ± 54.3 | < 0.0009*** |
| Major bleeding | 0.07% (n = 24) | 0.15% (n = 149) | < 0.0009*** |
| MACE | 0.1% (n = 37) | 0.09% (n = 89) | 0.68 |
| Myocardial infarction | 0.04% (n = 16) | 0.04% (n = 37) | 0.58 |
| TIA/stroke | 0.03% (n = 12) | 0.02% (n = 21) | 0.33 |
| Death | 0.3% (n = 9) | 0.03% (n = 32) | 0.56 |
| Access site complication | 0.02% (n = 91) | 0.07% (n = 726) | < 0.0009*** |
| All NSTEMI | 3.067 (15.2%) | 17.062 (84.8%) | |
| Procedure time (min) | 38.9 ± 25.4 | 40.3 ± 26.4 | < 0.009** |
| Fluoroscopy time | 9.47 ± 8.5 | 8.61 ± 8.72 | < 0.0009*** |
| Contrast dye (ml) | 66.2 ± 39.2 | 73.8 ± 45.1 | < 0.0009*** |
| Major bleeding | 0.16 (n = 5) | 0.32% (n = 54) | 0.20 |
| MACE in NSTEMI | 0.16% (n = 5) | 0.36% (n = 62) | 0.11 |
| Myocardial infarction | 0.02% (n = 1) | 0.03% (n = 4) | 1 |
| TIA/stroke | 0.0% (n = 0) | 0.04% (n = 7) | 0.55 |
| Death | 0.13% (n = 4) | 0.30% (n = 52) | 0.15 |
| Access site complication NSTEMI | 0.2% (n = 7) | 0.8% (n = 131) | < 0.009** |
| All STEMI | 1.578 (11%) | 12.821 (89%) | |
| Procedure time (min) | 57.9 ± 34.6 | 61.6 ± 38.9 | < 0.0009*** |
| Fluoroscopy time (min) | 8.69 ± 8.54 | 8.12 ± 8.56 | 0.02* |
| Contrast dye (ml) | 57.9 ± 34.6 | 61.6 ± 38.9 | < 0.009** |
| Major bleeding | 0.06 (n = 1) | 0.39% (n = 50) | 0.066 |
| MACE in STEMI | 0.6% (n = 10) | 1.1% (n = 141/12821) | 0.11 |
| Myocardial infarction | 0.0% (n = 0) | 0.05% (n = 6) | 0.84 |
| TIA/stroke | 0.0% (n = 0) | 0.01% (n = 6) | 0.84 |
| Death | 0.06% (n = 10) | 1.0% (n = 129) | 0.196 |
| Access site complication STEMI | 0.06% (n = 1) | 0.7% (n = 94) | < 0.009** |
| All unstable angina | 5.596 (25.8%) | 16.074 (74.2%) | |
| Procedure time (min) | 31.8 ± 22.3 | 37.3 ± 25.6 | < 0.009** |
| Fluoroscopy time | 7.79 ± 7.21 | 7.76 ± 8.2 | 0.8 |
| Contrast dye (ml) | 59.9 ± 35.2 | 73.9 ± 46.6 | < 0.009** |
| Major bleeding | 0.02 (n = 1) | 0.17% (n = 27) | 0.013 |
| MACE in unstable angina | 0.03% (n = 2) | 0.3% (n = 50) | < 0.0009*** |
| Myocardial infarction | 0.02% (n = 1) | 0.02% (n = 3) | 1 |
| TIA/stroke | 0.02% (n = 1) | 0.02% (n = 3) | 1 |
| Death | 0.0% (n = 0) | 0.27% (n = 44) | < 0.0009*** |
| Access site complication in unstable angina | 0.02% (n = 9) | 0.05% (n = 85) | < 0.0009*** |
| Cardiogenic shock | 202 (7.8%) | 2379 (92.2%) | |
| Major bleeding | 0 (n = 0) | 0.084% (n = 2) | 1 |
| MACE | 5.4% (n = 11) | 6.9% (n = 165) | 0.5 |
| Myocardial infarction | 0.0% (n = 0) | 0.04% (n = 1) | 1 |
| TIA/stroke | 0.0% (n = 0) | 0.0% (n = 0) | 1 |
| Death | 5.4% (n = 11) | 6.89% (n = 164) | 0.52 |